Navigation Links
The basis of a new bioinsecticide is developed to control a pest of banana plantations

Certain micro-organisms can constitute the active matter to develop bioinsecticides used for pest control. In this case, the researcher used a virus of the baculovirus family, which specifically infect invertebrates and naturally regulate the population of insects of this type on the ground. "We selected a virus that displayed the best insecticidal characteristics," she explained. "Using this virus we developed a large-scale production system by means of which we could treat a surface area equivalent to that of a football pitch using just two larvae."

When a larva infected by the virus dies, it constitutes a fresh source of infection because it contaminates the area where the crops are growing. So other larvae that feed in this area may be infected and die in the same way. To verify the effectiveness of the bioinsecticide, the results were compared with those of the chemical and biological insecticides routinely used on banana plantations on the Canary Islands. "We saw that our product is between 3 and 4 times more effective. We applied for a patent and established the bases to develop a new bioinsecticide, which is also a very useful tool for sustainable agriculture."

In this respect, controlling the pest using the usual treatments, like chemical insecticides, can lead to environmental hazards and leave residues on the surface of the crops, which hampers the marketing of them. "Baculoviruses have generated an interest in the control of insect pests, because of their insecticidal capacity and because of their specificity and safety of use," pointed out Alexandra Bernal, "so some have already been registered as insecticides in several parts of the world."


Contact: Oihane Lakar Iraizoz
Elhuyar Fundazioa

Page: 1

Related biology news :

1. Researchers identify genetic basis of cardiac, craniofacial birth defects
2. International team discovers likely basis of birth defect causing premature skull closure in infants
3. Researchers discover genetic basis for eczema, new avenue to therapies
4. Molecular basis identified for tissue specific immune regulation in the eye and kidney
5. Dartmouth neuroscientist finds free will has neural basis
6. Unraveling the scientific basis of the infant feeding axiom breast is best
7. Notre Dame paper sheds light on genetic and physiological basis for metabolic diseases
8. Basis Extends Series B to more than $23 Million; Announces Mobile Veteran, Ethan Fassett, as VP of Product
9. TGen, Barrow and PCH receive $4 million grant to study genetic basis of brain injuries
10. Researchers complete a milestone in defining the genetic basis of rheumatoid arthritis
11. Red alert: Body kills spontaneous blood cancers on a daily basis
Post Your Comments:
(Date:10/29/2015)... , Oct. 29, 2015  Rubicon Genomics, ... for U.S. distribution of its DNA library preparation ... and Rubicon,s new ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq ... the preparation of NGS libraries for liquid biopsies--the ... diagnostic and prognostic applications in cancer and other ...
(Date:10/27/2015)... -- Munich, Germany , October ... automatically maps data from mobile eye tracking videos created ... that they can be quantitatively analyzed with SMI,s analysis ... , October 28-29, 2015. SMI,s Automated Semantic Gaze ... tracking videos created with SMI,s Eye Tracking Glasses ...
(Date:10/23/2015)... , Oct. 23, 2015 Research and ... the "Global Voice Recognition Biometrics Market 2015-2019" ... --> The global voice recognition biometrics ... 2014-2019. --> --> ... has been prepared based on an in-depth market analysis ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... CITY , Nov. 25, 2015 /PRNewswire/ - Aeterna ... affirms that its business and prospects remain fundamentally ... , Zoptrex™ (zoptarelin doxorubicin) recently received DSMB recommendation ... to completion following review of the final interim ... Phase 2 Primary Endpoint in men with heavily ...
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica Richman and Zachary Apte, ... their initial angel funding process. Now, they are paying it forward to other ... stage investments in the microbiome space. In this, they join other successful ...
(Date:11/24/2015)... Therapeutics, Inc. (NASDAQ: HALO ) will be presenting at the ... on Wednesday, December 2 at 9:30 a.m. ET/6:30 a.m. PT . ... a corporate overview. th Annual Oppenheimer Healthcare Conference ... a.m. PT . Jim Mazzola , vice president of ... --> th Annual Oppenheimer Healthcare Conference in ...
(Date:11/24/2015)... , Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris ... of IIROC on behalf of the Toronto Stock Exchange, ... release there are no corporate developments that would cause ... --> --> About Aeterna ... . --> Aeterna Zentaris is a ...
Breaking Biology Technology: